Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ITCI - Intra-Cellular Therapies, Inc.
17.8 M
LAST VALUE
24.34%
2 YEAR CAGR
91.85%
5 YEAR CAGR
-7.92%
10 YEAR CAGR